Transactions
Affichage de - 891 éléments sur 968
-
US$74m
Dexcom May 2011
Sole Book-Runner (Bought Deal)
-
Symphony Technology Group
Financial Advisor to Symphony Technology Group on its acquisition of ImpactRX
-
$54m
Tranzyme Pharma
Co-Manager (IPO)
-
US$50m
Anthera Pharmaceuticals
Co-Lead Manager (Follow-on Offering)
-
MediMedia
Financial Advisor to MediMedia on its sale of MediMedia Information Technologies to Susquehanna Growth Equity
-
US$104.8m
Amarin Mar 2011
Co-Lead Manager (Follow-on Offering)
-
$3.0m
Annidis Health Systems
Lead Manager (Private Placement)
-
$5m
Genesis Biopharma
Co-Lead Manager (Private Placement)
-
US$40m
AcelRx Pharmaceuticals
Co-Manager (IPO)
